FDA approves first new ADHD drug in over a decade for children
The Hindu
Experts say the drug, Qelbree, may appeal to parents who don't want to give their child stimulants.
U.S. regulators have approved the first new drug in over a decade for children with , (attention deficit hyperactivity disorder) which causes inattention, hyperactivity and impulsivity. Also read: The Food and Drug Administration late Friday approved Qelbree (KELL'-bree for treating attention deficit hyperactivity disorder in children ages 6 to 17. It comes as a capsule that's taken daily.More Related News